Stay updated on Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Sign up to get notified when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now shows an updated ClinicalTrials.gov revision/version number (from v3.5.2 to v3.5.3) in the footer, indicating a platform release rather than a change to the trial’s record details.
    Difference
    0.1%
    Check dated 2026-04-24T22:27:37.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T14:19:02.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; Revision: v3.4.3 removed in the record history.
    Difference
    0.1%
    Check dated 2026-03-20T00:11:24.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-12T19:36:24.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    New history entry 'Revision: v3.4.2' was added and an earlier 'Revision: v3.4.1' entry plus a site-wide funding notice were removed. These changes affect only the history metadata and do not modify study data or core page content.
    Difference
    0.7%
    Check dated 2026-02-11T20:36:51.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The additions include a site-wide notice about government funding status and a new revision label (v3.4.1), and the previous revision (v3.4.0) was removed; these are metadata changes and do not affect the study's record content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-04T10:54:01.000Z thumbnail image

Stay in the know with updates to Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase I Study of MIK665 Mcl-1 Inhibitor in Lymphoma or Myeloma Clinical Trial page.